Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy

Area of Science:

• Immunogenetics
• Sleep Medicine
• Human Genetics

Background:

• Narcolepsy is a sleep disorder strongly linked to HLA DR15 (DR2).
• Understanding the genetic basis of narcolepsy beyond HLA DR15 is crucial for identifying susceptibility genes.
• The HLA class II region contains candidate genes that may influence narcolepsy risk.

Purpose of the Study:

• To investigate HLA class II genes in narcolepsy patients who are negative for HLA DR15.
• To identify specific HLA alleles and polymorphisms associated with narcolepsy in a non-DR15 cohort.
• To pinpoint primary candidate susceptibility genes for narcolepsy within the HLA class II region.

Main Methods:

• Genotyping of HLA DRB1, DQA1, and DQB1 loci in 58 non-DR15 narcolepsy-cataplexy patients.
• Analysis of additional markers including DQA1 and DQB1 gene promoters and microsatellite polymorphisms.
• Haplotype analysis to identify shared genetic markers among patients.

Main Results:

• Twenty-one (36%) of the 58 non-DR15 patients carried the DQA1*0102 and DQB1*0602 alleles.
• These DQA1*0102/DQB1*0602 alleles were present in a DQ1 subtype typically associated with DRB1*15 in DR2-positive narcolepsy.
• No specific HLA DR or DQ alleles were shared among the 37 non-DQA1*0102/DQB1*0602 subjects.

Conclusions:

• HLA DQA1*0102 and DQB1*0602 are identified as the most probable primary candidate susceptibility genes for narcolepsy.
• These specific alleles confer susceptibility to narcolepsy independently of the previously established HLA DR15 association.
• The findings refine our understanding of the genetic architecture of narcolepsy within the HLA class II region.